BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15746045)

  • 1. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer.
    Bani-Hani KE; Almasri NM; Khader YS; Sheyab FM; Karam HN
    Clin Cancer Res; 2005 Feb; 11(4):1447-53. PubMed ID: 15746045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer.
    Sumiyoshi Y; Kakeji Y; Egashira A; Mizokami K; Orita H; Maehara Y
    Clin Cancer Res; 2006 Sep; 12(17):5112-7. PubMed ID: 16951228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
    Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
    Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
    J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
    Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
    Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
    Tenderenda M
    J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
    Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
    Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
    Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
    J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cell-cycle regulators, cyclin E and p21WAF1/CIP1, potential prognostic markers for gastric cancer.
    Jang SJ; Park YW; Park MH; Lee JD; Lee YY; Jung TJ; Kim IS; Choi IY; Ki M; Choi BY; Ahn MJ
    Eur J Surg Oncol; 1999 Apr; 25(2):157-63. PubMed ID: 10218458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cooperative role of p27 with cyclin E in the prognosis of advanced gastric carcinoma.
    Xiangming C; Natsugoe S; Takao S; Hokita S; Tanabe G; Baba M; Kuroshima K; Aikou T
    Cancer; 2000 Sep; 89(6):1214-9. PubMed ID: 11002215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer.
    Eltabbakh GH; Belinson JL; Kennedy AW; Biscotti CV; Casey G; Tubbs RR; Blumenson LE
    Cancer; 1997 Sep; 80(5):892-8. PubMed ID: 9307189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status.
    Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
    J Exp Ther Oncol; 1996 Mar; 1(2):88-94. PubMed ID: 9414392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of p53 protein expression for patients with gastric cancer--a multivariate analysis.
    Maehara Y; Tomoda M; Hasuda S; Kabashima A; Tokunaga E; Kakeji Y; Sugimachi K
    Br J Cancer; 1999 Mar; 79(7-8):1255-61. PubMed ID: 10098768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of cell cycle regulators in gastric carcinoma].
    Wu JF; Shao JC; Wang DB; Qin R; Zhang H
    Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins.
    Pan W; Ishii H; Ebihara Y; Gobe G
    J Surg Oncol; 2003 Feb; 82(2):104-10. PubMed ID: 12561066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
    Burke L; Flieder DB; Guinee DG; Brambilla E; Freedman AN; Bennett WP; Jones RT; Borkowski A; Caporaso NA; Fleming M; Trastek V; Pairolero P; Tazelaar H; Midthun D; Jett JR; Liotta LA; Travis WD; Harris CC
    Clin Cancer Res; 2005 Jan; 11(1):232-41. PubMed ID: 15671551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
    Grabowski P; Schrader J; Wagner J; Hörsch D; Arnold R; Arnold CN; Georgieva I; Stein H; Zeitz M; Daniel PT; Sturm I
    Clin Cancer Res; 2008 Nov; 14(22):7378-84. PubMed ID: 19010853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.